Mr Richard Fulton Pollock

Covalence Research Ltd, Harpenden (United Kingdom of Great Britain & Northern Ireland)

Membership: ESC Professional Member

Contributor content

$Ferric derisomaltose versus usual care in patients with heart failure, reduced ejection fraction, and iron deficiency: a short-term UK cost-utility analysis based on the IRONMAN RCT$

Presentation

Ferric derisomaltose versus usual care in patients with heart failure, reduced ejection fraction, and iron deficiency: a short-term UK cost-utility analysis based on the IRONMAN RCT

Explore sponsored resources

Mr Richard Fulton Pollock

Contributor content

Ferric derisomaltose versus usual care in patients with heart failure, reduced ejection fraction, and iron deficiency: a short-term UK cost-utility analysis based on the IRONMAN RCT

ESC 365 is supported by